Treatments

Products

Conditions

About Ellex

Investors

No results found

Check the spelling or try searching for a more general term.

Select your location

キャリア

エレックス社の使命は、眼科外科医が眼疾患を効果的かつ有効的に治療できるよう革新的な製品を開発することです。

当社チームのメンバーは全員、貢献できる何か重要なものを備えています。そのため、当社は、眼科技術の役割を進めるために働く流動的な人材を常に探し求めています。

エレックスの安全性、福祉、顧客重視性、継続的な改善、積極的な姿勢を実践できる方は、当社の現在のキャリア一覧をご覧ください。

LinkedIn 検索
Join our mailing list
Contact us
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More

QUANTEL MEDICAL COMPLETES ACQUISITION OF ELLEX

Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical.

The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of the leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.

More Information